Through presentations and the use of interactive conversations, Jeff Devido, MD, and Martin Epson, MD will focus on four hallucinogens and neurobiological reasons for why they are emerging as effective treatment for addictive disorders.
At the end of the program, participants will be better able to:
Describe common classification system for hallucinogens
Explain why hallucinogens may present a unique opportunity for treatment of addictive disorders
Discuss emerging evidence of effectiveness of major hallucinogens